294 related articles for article (PubMed ID: 16329077)
1. Generation of neoantigenic epitopes after posttranslational modification of type II collagen by factors present within the inflamed joint.
Nissim A; Winyard PG; Corrigall V; Fatah R; Perrett D; Panayi G; Chernajovsky Y
Arthritis Rheum; 2005 Dec; 52(12):3829-38. PubMed ID: 16329077
[TBL] [Abstract][Full Text] [Related]
2. Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse.
Burkhardt H; Koller T; Engström A; Nandakumar KS; Turnay J; Kraetsch HG; Kalden JR; Holmdahl R
Arthritis Rheum; 2002 Sep; 46(9):2339-48. PubMed ID: 12355481
[TBL] [Abstract][Full Text] [Related]
3. Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis.
Burkhardt H; Sehnert B; Bockermann R; Engström A; Kalden JR; Holmdahl R
Eur J Immunol; 2005 May; 35(5):1643-52. PubMed ID: 15832289
[TBL] [Abstract][Full Text] [Related]
4. Citrullination of synovial proteins in murine models of rheumatoid arthritis.
Vossenaar ER; Nijenhuis S; Helsen MM; van der Heijden A; Senshu T; van den Berg WB; van Venrooij WJ; Joosten LA
Arthritis Rheum; 2003 Sep; 48(9):2489-500. PubMed ID: 13130468
[TBL] [Abstract][Full Text] [Related]
5. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
[TBL] [Abstract][Full Text] [Related]
6. Anti-Human type II collagen CD19+ B cells are present in patients with rheumatoid arthritis and healthy individuals.
He X; Kang AH; Stuart JM
J Rheumatol; 2001 Oct; 28(10):2168-75. PubMed ID: 11669151
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of T cells reactive to type II collagen in synovial fluid of patients with rheumatoid arthritis.
He X; Kang AH; Stuart JM
J Rheumatol; 2000 Mar; 27(3):589-93. PubMed ID: 10743794
[TBL] [Abstract][Full Text] [Related]
8. Glycosylation of type II collagen is of major importance for T cell tolerance and pathology in collagen-induced arthritis.
Bäcklund J; Treschow A; Bockermann R; Holm B; Holm L; Issazadeh-Navikas S; Kihlberg J; Holmdahl R
Eur J Immunol; 2002 Dec; 32(12):3776-84. PubMed ID: 12516572
[TBL] [Abstract][Full Text] [Related]
9. Type II collagen antibody response is enriched in the synovial fluid of rheumatoid joints and directed to the same major epitopes as in collagen induced arthritis in primates and mice.
Lindh I; Snir O; Lönnblom E; Uysal H; Andersson I; Nandakumar KS; Vierboom M; 't Hart B; Malmström V; Holmdahl R
Arthritis Res Ther; 2014 Jul; 16(4):R143. PubMed ID: 25005029
[TBL] [Abstract][Full Text] [Related]
10. Enhanced T cell proliferative response to type II collagen and synthetic peptide CII (255-274) in patients with rheumatoid arthritis.
Kim HY; Kim WU; Cho ML; Lee SK; Youn J; Kim SI; Yoo WH; Park JH; Min JK; Lee SH; Park SH; Cho CS
Arthritis Rheum; 1999 Oct; 42(10):2085-93. PubMed ID: 10524679
[TBL] [Abstract][Full Text] [Related]
11. Pattern of humoral reactivity to type II collagen in rheumatoid arthritis.
Boissier MC; Chiocchia G; Texier B; Fournier C
Clin Exp Immunol; 1989 Nov; 78(2):177-83. PubMed ID: 12412745
[TBL] [Abstract][Full Text] [Related]
12. [T cell proliferative response and antibody formation to citrullinated collagen type II in patients with rheumatoid arthritis].
Tian X; Zhao Y; Li ZG
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):673-6. PubMed ID: 19595060
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic antibody recognition of cartilage.
Nandakumar KS
Cell Tissue Res; 2010 Jan; 339(1):213-20. PubMed ID: 19506910
[TBL] [Abstract][Full Text] [Related]
14. Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells.
Nandakumar KS; Bäcklund J; Vestberg M; Holmdahl R
Arthritis Res Ther; 2004; 6(6):R544-50. PubMed ID: 15535832
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies to posttranslationally modified type II collagen as potential biomarkers for rheumatoid arthritis.
Strollo R; Ponchel F; Malmström V; Rizzo P; Bombardieri M; Wenham CY; Landy R; Perret D; Watt F; Corrigall VM; Winyard PG; Pozzilli P; Conaghan PG; Panayi GS; Klareskog L; Emery P; Nissim A
Arthritis Rheum; 2013 Jul; 65(7):1702-12. PubMed ID: 23575908
[TBL] [Abstract][Full Text] [Related]
16. Midkine, a heparin-binding growth factor, is fundamentally involved in the pathogenesis of rheumatoid arthritis.
Maruyama K; Muramatsu H; Ishiguro N; Muramatsu T
Arthritis Rheum; 2004 May; 50(5):1420-9. PubMed ID: 15146411
[TBL] [Abstract][Full Text] [Related]
17. Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody.
Golan I; Nedvetzki S; Golan I; Eshkar-Sebban L; Levartovsky D; Elkayam O; Caspi D; Aamar S; Amital H; Rubinow A; Naor D
J Autoimmun; 2007; 28(2-3):99-113. PubMed ID: 17383158
[TBL] [Abstract][Full Text] [Related]
18. Association between protein tyrosine phosphatase 22 variant R620W in conjunction with the HLA-DRB1 shared epitope and humoral autoimmunity to an immunodominant epitope of cartilage-specific type II collagen in early rheumatoid arthritis.
Burkhardt H; Hüffmeier U; Spriewald B; Böhm B; Rau R; Kallert S; Engström A; Holmdahl R; Reis A
Arthritis Rheum; 2006 Jan; 54(1):82-9. PubMed ID: 16385499
[TBL] [Abstract][Full Text] [Related]
19. Shift toward T helper 1 cytokines by type II collagen-reactive T cells in patients with rheumatoid arthritis.
Park SH; Min DJ; Cho ML; Kim WU; Youn J; Park W; Cho CS; Kim HY
Arthritis Rheum; 2001 Mar; 44(3):561-9. PubMed ID: 11263770
[TBL] [Abstract][Full Text] [Related]
20. An autoantigen-specific, highly restricted T cell repertoire infiltrates the arthritic joints of mice in an HLA-DR1 humanized mouse model of autoimmune arthritis.
Qian Z; Latham KA; Whittington KB; Miller DC; Brand DD; Rosloniec EF
J Immunol; 2010 Jul; 185(1):110-8. PubMed ID: 20511555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
